Pre-commercial procurement (PCP) to buy R&D (research and development) services to develop fully integrated, standardized NGS workflows, for routine diagnosis of common and rare cancers.

This PIN provides early information about the expected starting date and purchase volume for a pre-commercial procurement (PCP) and about the open market consultation that is organized in preparation of this procurement. More information about the open market consultation is provided in section II.2.14). The procurement aims to trigger new solutions to be developed and tested to address the following challenge: development of two fully integrated, standardized NGS workflows, from sample-pre-analytics to medical decision making, for routine diagnostics of common and rare cancers from adults and children. As the common challenge exists of a number of sub-challenges, the procurement will be divided into the following lots, each corresponding to one sub-challenge: — Lot 1: Pre-sequencing (Specimen collection, nucleic acid isolation, library preparation), — Lot 2: Sequencing, — Lot 3: Bioinformatics analysis, — Lot 4: Integrated reporting

Submissions will be accepted in English only.

Deadline for submitting offers: Date: 19.12.2021